{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:50:34Z","timestamp":1791435034752,"version":"4.3.3"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["14\/222\/02"],"award-info":[{"award-number":["14\/222\/02"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.psychres.2026.117469","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:45:35Z","timestamp":1790264735000},"page":"117469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lithium and quetiapine augmentation therapy in treatment-resistant depression with atypical features"],"prefix":"10.1016","volume":"366","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5872-547X","authenticated-orcid":false,"given":"Gianmarco","family":"Ingrosso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5866-0066","authenticated-orcid":false,"given":"Stefano","family":"Masier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2126-799X","authenticated-orcid":false,"given":"Armando","family":"D\u2019Agostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6990-939X","authenticated-orcid":false,"given":"Anthony J.","family":"Cleare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2026.117469_bib0001","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jad.2022.12.044","article-title":"Comorbidity and healthcare utilization in patients with treatment resistant depression: a large-scale retrospective cohort analysis using electronic health records","volume":"324","author":"Adekkanattu","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.psychres.2026.117469_bib0002","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0165-0327(83)90004-6","article-title":"Bipolar outcome in the course of depressive illness. Phenomenologic, familial, and pharmacologic predictors","volume":"5","author":"Akiskal","year":"1983","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2026.117469_bib0003","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5\u00ae)","year":"2013"},{"key":"10.1016\/j.psychres.2026.117469_bib0004","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR","year":"2022"},{"issue":"2","key":"10.1016\/j.psychres.2026.117469_bib0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-0327(02)00169-6","article-title":"Toward validation of atypical depression in the community: results of the Zurich cohort study","volume":"72","author":"Angst","year":"2002","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.psychres.2026.117469_bib0006","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jad.2013.05.079","article-title":"Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder","volume":"151","author":"Bauer","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"1\u20133","key":"10.1016\/j.psychres.2026.117469_bib0007","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jad.2010.08.032","article-title":"A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder","volume":"127","author":"Bauer","year":"2010","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.psychres.2026.117469_bib0008","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4088\/JCP.08m04629","article-title":"Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study","volume":"70","author":"Bauer","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2026.117469_bib0009","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s004060050067","article-title":"Prevalence of bipolar II disorder in atypical depression","volume":"249","author":"Benazzi","year":"1999","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.psychres.2026.117469_bib0010","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4088\/JCP.10m06227","article-title":"Epidemiology of major depression with atypical features: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)","volume":"73","author":"Blanco","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"n\/a","key":"10.1016\/j.psychres.2026.117469_bib0011","article-title":"Patients with Atypical symptoms of depression respond better to lithium augmentation than Patients without Atypical symptoms","volume":"n\/a","author":"Buchbauer","year":"2026","journal-title":"Acta Psychiatr. Scand."},{"issue":"1","key":"10.1016\/j.psychres.2026.117469_bib0012","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/npp.2016.123","article-title":"Role of adiposity-driven inflammation in depressive morbidity","volume":"42","author":"Capuron","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.psychres.2026.117469_bib0013","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/bcp.14193","article-title":"The Medication Adherence Report Scale: a measurement tool for eliciting patients\u2019 reports of nonadherence","volume":"86","author":"Chan","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.psychres.2026.117469_bib0014","doi-asserted-by":"crossref","first-page":"f3646","DOI":"10.1136\/bmj.f3646","article-title":"Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis","volume":"346","author":"Cipriani","year":"2013","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.psychres.2026.117469_bib0015","article-title":"Lithium versus antidepressants in the long-term treatment of unipolar affective disorder","volume":"2009","author":"Cipriani","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.psychres.2026.117469_bib0018","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0269881115581093","article-title":"Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines","volume":"29","author":"Cleare","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2026.117469_bib0016","first-page":"276","article-title":"Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression: a pragmatic, open-label, parallel-group, randomised controlled superiority trial in the UK. The Lancet","volume":"12","author":"Cleare","year":"2025","journal-title":"Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2026.117469_bib0017","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0269881115581093","article-title":"Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines","volume":"29","author":"Cleare","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2026.117469_bib0019","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1017\/S0033291709006114","article-title":"The effects of psychotherapy for adult depression are overestimated: a meta-analysis of study quality and effect size","volume":"40","author":"Cuijpers","year":"2010","journal-title":"Psychol. Med."},{"issue":"5","key":"10.1016\/j.psychres.2026.117469_bib0020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archpsyc.1982.04290050015005","article-title":"Atypical depression","volume":"39","author":"Davidson","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2026.117469_bib0021","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0165-1781(92)90067-D","article-title":"Secondary social phobia in patients with major depression","volume":"44","author":"Dilsaver","year":"1992","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.psychres.2026.117469_bib0022","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1185\/030079906X162809","article-title":"Quetiapine augmentation of treatment-resistant depression: a comparison with lithium","volume":"23","author":"Dor\u00e9e","year":"2007","journal-title":"Curr. Med. Res. Opin."},{"issue":"5","key":"10.1016\/j.psychres.2026.117469_bib0023","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4088\/JCP.v67n0501","article-title":"Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression","volume":"67","author":"Dunner","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.psychres.2026.117469_bib0024","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1017\/S1461145710000015","article-title":"Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study","volume":"13","author":"El-Khalili","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.psychres.2026.117469_bib0025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1192\/bjp.bp.111.102665","article-title":"Prediction of longer-term outcome of treatment-resistant depression in tertiary care","volume":"201","author":"Fekadu","year":"2012","journal-title":"Br. J. Psychiatry: J. Ment. Sci."},{"issue":"2","key":"10.1016\/j.psychres.2026.117469_bib0027","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4088\/JCP.08m04309","article-title":"A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method","volume":"70","author":"Fekadu","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.psychres.2026.117469_bib0026","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jad.2008.10.014","article-title":"What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies","volume":"116","author":"Fekadu","year":"2009","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.psychres.2026.117469_bib0028","first-page":"266","article-title":"Atypical depression is associated with metabolic syndrome: a systematic review","volume":"50","author":"Ferriani","year":"2022","journal-title":"Actas Esp. Psiquiatr."},{"issue":"3","key":"10.1016\/j.psychres.2026.117469_bib0029","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jad.2010.01.004","article-title":"Reducing the hypomania checklist (HCL-32) to a 16-item version","volume":"124","author":"Forty","year":"2010","journal-title":"J. Affect. Disord."},{"issue":"15","key":"10.1016\/j.psychres.2026.117469_bib0030","first-page":"1517","article-title":"Depression is the leading cause of disability around the world","volume":"317","author":"Friedrich","year":"2017","journal-title":"JAMa"},{"issue":"1","key":"10.1016\/j.psychres.2026.117469_bib0031","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2026.117469_bib0032","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.eurpsy.2010.01.010","article-title":"Treatment of atypical depression: post-hoc analysis of a randomized controlled study testing the efficacy of sertraline and cognitive behavioural therapy in mildly depressed outpatients","volume":"25","author":"Henkel","year":"2010","journal-title":"Eur. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117469_bib0033","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00005053-197209000-00009","article-title":"Treatment of previously intractable depressions with tranylcypromine and lithium","volume":"155","author":"Himmelhoch","year":"1972","journal-title":"J. Nerv. Ment. Dis."},{"issue":"2","key":"10.1016\/j.psychres.2026.117469_bib0034","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0165-0327(92)90043-6","article-title":"The validity of major depression with atypical features based on a community study","volume":"26","author":"Horwath","year":"1992","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.psychres.2026.117469_bib0035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/archpsyc.56.5.431","article-title":"Treatment of Atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial","volume":"56","author":"Jarrett","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117469_bib0036","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/da.20001","article-title":"Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline","volume":"19","author":"Joyce","year":"2004","journal-title":"Depress. Anxiety"},{"issue":"5","key":"10.1016\/j.psychres.2026.117469_bib0037","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archpsyc.1996.01830050025004","article-title":"The identification and validation of distinct depressive syndromes in a population-based sample of female twins","volume":"53","author":"Kendler","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117469_bib0038","series-title":"Diagnosis And Drug Treatment Of Psychiatric Disorders","author":"Klein","year":"1969"},{"issue":"7","key":"10.1016\/j.psychres.2026.117469_bib0039","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1176\/ajp.154.7.934","article-title":"Reversed neurovegetative symptoms of depression: a community study of Ontario","volume":"154","author":"Levitan","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117469_bib0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12991-019-0248-0","article-title":"All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population","volume":"18","author":"Li","year":"2019","journal-title":"Ann. Gen. Psychiatry"},{"issue":"7","key":"10.1016\/j.psychres.2026.117469_bib0042","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/archpsyc.1984.01790180039005","article-title":"Phenelzine v imipramine in atypical depression. A preliminary report","volume":"41","author":"Liebowitz","year":"1984","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2026.117469_bib0041","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archpsyc.1988.01800260037004","article-title":"Antidepressant specificity in atypical depression","volume":"45","author":"Liebowitz","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117469_bib0043","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0165-0327(94)90015-9","article-title":"Moclobemide and fluoxetine in atypical depression: a double-blind trial","volume":"32","author":"Lonnqvist","year":"1994","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.psychres.2026.117469_bib0044","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archpsyc.1995.03950150062011","article-title":"Generalized social phobia. Reliability and validity","volume":"52","author":"Mannuzza","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2026.117469_bib0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12888-017-1393-0","article-title":"Study protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression (the LQD study)","volume":"17","author":"Marwood","year":"2017","journal-title":"BMC. Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2026.117469_bib0046","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/archpsyc.60.8.817","article-title":"Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences","volume":"60","author":"Matza","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2026.117469_bib0047","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.comppsych.2005.03.002","article-title":"Increased personality disorders and Axis I comorbidity in atypical depression","volume":"46","author":"McGinn","year":"2005","journal-title":"Compr. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117469_bib0048","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1176\/appi.ajp.157.3.344","article-title":"A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of Atypical depression","volume":"157","author":"McGrath","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2026.117469_bib0049","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1176\/ajp.150.1.118","article-title":"A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression","volume":"150","author":"McGrath","year":"1993","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2026.117469_bib0050","first-page":"166","article-title":"A pilot sequential study of cognitive therapy and pharmacotherapy of atypical depression","volume":"53","author":"Mercier","year":"1992","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117469_bib0051","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry: J. Ment. Sci."},{"issue":"3","key":"10.1016\/j.psychres.2026.117469_bib0052","first-page":"205","article-title":"An open-label, rater-blinded, flexible-dose, 8-week trial of escitalopram in patients with major depressive disorder with atypical features","volume":"10","author":"Pae","year":"2008","journal-title":"Prim. Care Companion. J. Clin. Psychiatry"},{"issue":"10","key":"10.1016\/j.psychres.2026.117469_bib0053","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0006-3223(95)00628-1","article-title":"Fluoxetine versus phenelzine in atypical depression","volume":"40","author":"Pande","year":"1996","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.psychres.2026.117469_bib0054","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1176\/appi.ajp.159.9.1470","article-title":"Atypical depression: a reappraisal","volume":"159","author":"Parker","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117469_bib0055","article-title":"Immuno-metabolic depression: from concept to implementation","volume":"48","author":"Penninx","year":"2025","journal-title":"Lancet Reg. Health \u2013 Eur."},{"issue":"2","key":"10.1016\/j.psychres.2026.117469_bib0056","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0010-440X(98)90080-3","article-title":"The high prevalence of \u201csoft\u201d bipolar (II) features in atypical depression","volume":"39","author":"Perugi","year":"1998","journal-title":"Compr. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2026.117469_bib0057","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/archpsyc.1991.01810280035005","article-title":"Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design","volume":"48","author":"Quitkin","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"issue":"10","key":"10.1016\/j.psychres.2026.117469_bib0058","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archpsyc.1990.01810220051006","article-title":"Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication","volume":"47","author":"Quitkin","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117469_bib0059","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1176\/ajp.145.3.306","article-title":"Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders","volume":"145","author":"Quitkin","year":"1988","journal-title":"Am. J. Psychiatry"},{"issue":"S21","key":"10.1016\/j.psychres.2026.117469_bib0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1192\/S0007125000292465","article-title":"Columbia Atypical depression: a subgroup of depressives with better response to MAOI than to tricyclic antidepressants or Placebo","volume":"163","author":"Quitkin","year":"1993","journal-title":"Br. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2026.117469_bib0061","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1600-0447.1996.tb09884.x","article-title":"Atypical depressive symptoms and clusters in unipolar and bipolar depression","volume":"94","author":"Robertson","year":"1996","journal-title":"Acta Psychiatr. Scand."},{"issue":"10","key":"10.1016\/j.psychres.2026.117469_bib0062","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/gps.1201","article-title":"An open trial of venlafaxine for the treatment of late-life atypical depression","volume":"19","author":"Roose","year":"2004","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2026.117469_bib0063","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2474-11-120","article-title":"Atypical depression is more common than melancholic in fibromyalgia: an observational cohort study","volume":"11","author":"Ross","year":"2010","journal-title":"BMC Musculoskelet. Disord."},{"issue":"1","key":"10.1016\/j.psychres.2026.117469_bib0064","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0197-2456(03)00112-0","article-title":"Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design","volume":"25","author":"Rush","year":"2004","journal-title":"Control. Clin. Trials"},{"issue":"3","key":"10.1016\/j.psychres.2026.117469_bib0065","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S0033291700035558","article-title":"The Inventory of depressive symptomatology (IDS): psychometric properties","volume":"26","author":"Rush","year":"1996","journal-title":"Psychol. Med."},{"issue":"5","key":"10.1016\/j.psychres.2026.117469_bib0066","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-item Quick Inventory of Depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.psychres.2026.117469_bib0067","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1176\/appi.ajp.2011.10111645","article-title":"Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study","volume":"168","author":"Rush","year":"2011","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2026.117469_bib0068","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"5270","key":"10.1016\/j.psychres.2026.117469_bib0069","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/bmj.1.5270.6","article-title":"Treatment of anxiety states by antidepressant drugs","volume":"1","author":"Sargant","year":"1962","journal-title":"Br. Med. J."},{"issue":"3","key":"10.1016\/j.psychres.2026.117469_bib0070","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jad.2007.10.025","article-title":"Atypical symptoms in hospitalised patients with major depressive episode: frequency, clinical characteristics, and internal validity","volume":"108","author":"Seem\u00fcller","year":"2008","journal-title":"J. Affect. Disord."},{"issue":"Suppl 20","key":"10.1016\/j.psychres.2026.117469_bib0071","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2026.117469_bib0072","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/026988119901300412","article-title":"A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression","volume":"13","author":"S\u00f6gaard","year":"1999","journal-title":"J. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.psychres.2026.117469_bib0073","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.psychres.2026.117469_bib0074","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/YIC.0b013e32830dd296","article-title":"Is duloxetine effective treatment for depression with atypical features?","volume":"23","author":"Stewart","year":"2008","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2026.117469_bib0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00004850-199100630-00007","article-title":"A double-blind parallel study comparing fluoxetine with imipramine in the treatment of atypical depression","volume":"6","author":"Stratta","year":"1991","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2026.117469_bib0076","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1192\/bjp.2018.233","article-title":"Augmentation therapies for treatment-resistant depression: systematic review and meta-analysis","volume":"214","author":"Strawbridge","year":"2019","journal-title":"Br. J. Psychiatry: J. Ment. Sci."},{"issue":"10","key":"10.1016\/j.psychres.2026.117469_bib0077","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1176\/ajp.155.10.1398","article-title":"Latent class analysis of lifetime depressive symptoms in the national comorbidity survey","volume":"155","author":"Sullivan","year":"1998","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2026.117469_bib0078","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1007\/BF02850218","article-title":"Comparison of the effectiveness of reboxetine versus fluoxetine in patients with atypical depression: a single-blind, randomized clinical trial","volume":"23","author":"Taner","year":"2006","journal-title":"Adv. Ther."},{"key":"10.1016\/j.psychres.2026.117469_bib0079","series-title":"The Maudsley Prescribing Guidelines in Psychiatry","author":"Taylor","year":"2025"},{"issue":"Suppl 8","key":"10.1016\/j.psychres.2026.117469_bib0080","first-page":"11","article-title":"Recognition and diagnosis of atypical depression","volume":"68","author":"Thase","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2026.117469_bib0081","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with Citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.psychres.2026.117469_bib0082","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.4088\/JCP.v69n1211","article-title":"Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features","volume":"69","author":"Trivedi","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2026.117469_bib0083","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0269881118822161","article-title":"Lithium treatment for unipolar major depressive disorder: systematic review","volume":"33","author":"Undurraga","year":"2019","journal-title":"J. Psychopharmacol. (Oxf.)"},{"issue":"4","key":"10.1016\/j.psychres.2026.117469_bib0084","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.jcp.0000227700.263.75.39","article-title":"Modafinil for Atypical depression: effects of open-label and double-blind discontinuation treatment","volume":"26","author":"Vaishnavi","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5136","key":"10.1016\/j.psychres.2026.117469_bib0085","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1136\/bmj.1.5136.1491","article-title":"Effects of iproniazid in depressive syndromes","volume":"1","author":"West","year":"1959","journal-title":"Br. Med. J."},{"issue":"2","key":"10.1016\/j.psychres.2026.117469_bib0086","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/da.23222","article-title":"Pharmacological and somatic treatment effects on suicide in adults: a systematic review and meta-analysis","volume":"39","author":"Wilkinson","year":"2022","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.psychres.2026.117469_bib0087","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neuroscience.2018.03.034","article-title":"The role of depressive subtypes within the neuroinflammation hypothesis of major depressive disorder","volume":"403","author":"Woelfer","year":"2019","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.psychres.2026.117469_bib0088","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S2215-0366(17)30232-8","article-title":"Lithium for long-term treatment of unipolar depression","volume":"4","author":"Young","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2026.117469_bib0089","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/depr.3050010506","article-title":"Atypical depression in an outpatient psychiatric population","volume":"1","author":"Zisook","year":"1993","journal-title":"Depression"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126005299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126005299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:10:50Z","timestamp":1791432650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178126005299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":89,"alternative-id":["S0165178126005299"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117469","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lithium and quetiapine augmentation therapy in treatment-resistant depression with atypical features","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117469","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117469"}}